Filing Details

Accession Number:
0001181431-11-046483
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-22 16:43:25
Reporting Period:
2011-08-18
Filing Date:
2011-08-22
Accepted Time:
2011-08-22 16:43:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205317 C Robert Young C/O Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-18 4,361 $7.44 5,611 No 4 M Direct
Common Stock Disposition 2011-08-18 4,361 $15.76 1,250 No 4 S Direct
Common Stock Acquisiton 2011-08-18 2,139 $7.44 3,389 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-08-18 4,361 $0.00 4,361 $7.44
Common Stock Stock Option (right to buy) Disposition 2011-08-18 2,139 $0.00 2,139 $7.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,139 2010-08-01 2020-06-16 No 4 M Direct
6,000 2010-08-01 2020-06-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect by Spouse
Footnotes
  1. ) These shares are held by Dr. Young's spouse. Dr. Young disclaims beneficial ownership over all such shares, except to the extent of his pecuniary interest therein.
  2. This option vests in twelve equal monthly installments, with the first tranche vesting on August 1, 2010.